The influence of propranolol, metoprolol, and mepindolol on mucociliary clearance in coronary heart disease patients without pulmonary disease
Dorow, P.; Weiss, T.; Felix, R.; Schmutzler, H.
International Journal of Clinical Pharmacology Therapy and Toxicology 22(2): 108-111
1984
ISSN/ISBN: 0174-4879 PMID: 6698664 Document Number: 225975
The effect of a beta-receptor blockade on the mucociliary clearance was studied in 24 patients without pulmonary disease but with coronary heart disease. No deterioration of mucociliary clearance was recorded under medication with 2 X 50 mg metoprolol or 2 X 2.5 mg mepindolol per day. In contrast, mucociliary clearance deteriorated significantly under medication with 2 X 40 mg propranolol.
Document emailed within 1 workday
Related Documents
Bonelli, J.; Magometschnigg, D.; Hitzenberger, G.; Kaik, G. 1978: Hemodynamics in patients with coronary heart disease under conditions of physical exercise before and after mepindolol-sulfate Zeitschrift für Kardiologie 67(1): 51-56Dorow, P.; Weiss, T.; Felix, R.; Schmutzler, H. 1987: Effect of a secretolytic and a combination of pinene, limonene and cineole on mucociliary clearance in patients with chronic obstructive pulmonary disease Arzneimittel-Forschung 37(12): 1378-1381
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Shoĭkhet, I.N.; Klester, E.B. 2010: Digestive system pathology in patients with chronic obstructive pulmonary disease concurrent with coronary heart disease Terapevticheskii Arkhiv 82(2): 25-28
Kozák, P. 1982: Increasing the sensitivity of systolic time intervals in coronary heart disease patients by means of stimulated tachycardia and pharmacological heart loads (isoproterenol, nitroglycerine, propranolol) Acta Universitatis Carolinae. Medica 28(5-6): 369-382
Zhdan, V.; Khaymenova, G.; Shilkina, L.; Martynyuk, D.; Babanina, M.; Mamontova, T. 2017: Determine the effectiveness of lipid-lowering therapy in patients with chronic obstructive pulmonary disease combined with coronary heart disease Wiadomosci Lekarskie 70(2 Part 2): 303-305
Zunnunov, Z.R. 2010: The clinical efficiency and safety of iodide-bromine balneotherapy in patients with coronary heart disease concurrent with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 82(1): 24-27
Akhmineeva, A.K. 2014: Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease Terapevticheskii Arkhiv 86(3): 20-23
Sypalo, A.; Kravchun, P.; Kadykova, O. 2017: The Influence of Mono- and Multivascular Lesions of Coronary Arteries on the Course of Coronary Heart Disease in Patients with Diabetes Mellitus type 2 Georgian Medical News 264: 61-65
Mauser, M.; Voelker, W.; Ickrath, O.; Hoffmeister, H.M.; Karsch, K.R. 1989: The acute hemodynamic effects of the new vasodilating beta blocker carvedilol in comparison with combined administration of nifedipine and propranolol in patients with coronary heart disease Zeitschrift für Kardiologie 78(11): 726-731
Pribylov, S.A. 2006: Pulmonary hypertension, endothelial dysfunction, and their correction with lisinopril in patients with heart failure in combination of ischemic heart disease and chronic obstructive pulmonary disease Kardiologiia 46(9): 36-40
Holtzman, E.; Rosenthal, T.; Goldbourt, U.; Segal, P. 1984: Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status Israel Journal of Medical Sciences 20(12): 1169-1176
Safwat, H.M.; Sharawy, M.; El Safouri, S. 1978: The effect of propranolol on the serum lipids in diabetics with coronary heart disease Journal of the Egyptian Medical Association 61(9-10): 577-583
Dixon, P.M. 1992: Respiratory mucociliary clearance in the horse in health and disease, and its pharmaceutical modification Veterinary Record 131(11): 229-235
Provotorov, V.M.; Budnevskiĭ, A.V.; Semenkova, G.G.; Shishkina, E.S. 2015: Proinflammatory Cytokines in Combination of Coronary Heart Disease and Chronic Obstructive Pulmonary Disease Klinicheskaia Meditsina 93(2): 5-9
Bova, A.A.; Lapitskiĭ, D.V. 2009: Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology Klinicheskaia Meditsina 87(2): 8-13
Carstens, V.; Haum, A.; Grond, M.; Behrenbeck, D.W. 1986: Incidence of coronary artery disease and necessity for coronary angiography in patients with valvular heart disease Zeitschrift für Kardiologie 75(Suppl 2): 83-85
Arntz, H.R.; Wunderlich, W.; Schnitzer, L.; Stern, R.; Fischer, F.; Agrawal, R.; Linderer, T.; Schultheiss, H.P. 1999: Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study Zeitschrift für Kardiologie 88(8): 582-590
Santos, M.J.; Llopis, J.; Mataix, F.J.; Urbano, G.; Lopez Jurado, M. 1996: Influence of dietary fish on fatty acid composition of the erythrocyte membrane in coronary heart disease patients International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 66(4): 378-385
Bolińska, H. 1978: Effect of propranolol on the ECG in patients with confirmed coronary disease Polski Tygodnik Lekarski 33(44): 1731-1733